Nuclear localization of E-cadherin but not beta-catenin in human ovarian granulosa cell tumours and normal ovarian follicles and ovarian stroma

Yoshihiro Ohishi, Yoshinao Oda, Shuichi Kurihara, Tsunehisa Kaku, Hiroaki Kobayashi, Norio Wake, Masazumi Tsuneyoshi

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Aims: The role of misregulated Wnt/beta-catenin signalling in human ovarian granulosa cell tumour (GCT) has not been well characterized. The aim of this study was to confirm subcellular localization of key molecules of Wnt signalling (beta-catenin and E-cadherin) in human ovarian GCTs. Methods and results: Tissue samples taken from 32 human ovarian GCTs and 19 human normal ovaries containing 68 follicles were stained immunohistochemically using monoclonal anti-beta-catenin and anti-E-cadherin antibodies. None of the 32 GCTs and none of the 68 ovarian follicles showed beta-catenin nuclear expression (0%). On the other hand, 28 of 32 GCTs (88%) and 53 of 68 normal ovarian follicles (78%) showed nuclear expression of E-cadherin in granulosa cells. The ovarian stroma in all 19 normal ovaries showed nuclear expression of E-cadherin but not beta-catenin. Membranous and cytoplasmic expression was observed variously in ovarian GCT, follicles and stroma. Conclusions: We have confirmed frequent nuclear localization of E-cadherin but not beta-catenin in human ovarian GCT, ovarian follicles and stroma. There is no evidence of misregulated Wnt/beta-catenin signalling (represented by nuclear expression of beta-catenin) in human ovarian GCT. Nuclear translocation of E-cadherin might contribute to ovarian folliculogenesis or granulosa/stromal cell differentiation.

Original languageEnglish
Pages (from-to)423-432
Number of pages10
JournalHistopathology
Volume58
Issue number3
DOIs
Publication statusPublished - Feb 1 2011

Fingerprint

Granulosa Cell Tumor
Ovarian Follicle
beta Catenin
Cadherins
Granulosa Cells
Ovary
Stromal Cells
Cell Differentiation
Antibodies

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Histology

Cite this

Nuclear localization of E-cadherin but not beta-catenin in human ovarian granulosa cell tumours and normal ovarian follicles and ovarian stroma. / Ohishi, Yoshihiro; Oda, Yoshinao; Kurihara, Shuichi; Kaku, Tsunehisa; Kobayashi, Hiroaki; Wake, Norio; Tsuneyoshi, Masazumi.

In: Histopathology, Vol. 58, No. 3, 01.02.2011, p. 423-432.

Research output: Contribution to journalArticle

Ohishi, Yoshihiro ; Oda, Yoshinao ; Kurihara, Shuichi ; Kaku, Tsunehisa ; Kobayashi, Hiroaki ; Wake, Norio ; Tsuneyoshi, Masazumi. / Nuclear localization of E-cadherin but not beta-catenin in human ovarian granulosa cell tumours and normal ovarian follicles and ovarian stroma. In: Histopathology. 2011 ; Vol. 58, No. 3. pp. 423-432.
@article{0db6a8f3de424c70bd50a1545f75ad28,
title = "Nuclear localization of E-cadherin but not beta-catenin in human ovarian granulosa cell tumours and normal ovarian follicles and ovarian stroma",
abstract = "Aims: The role of misregulated Wnt/beta-catenin signalling in human ovarian granulosa cell tumour (GCT) has not been well characterized. The aim of this study was to confirm subcellular localization of key molecules of Wnt signalling (beta-catenin and E-cadherin) in human ovarian GCTs. Methods and results: Tissue samples taken from 32 human ovarian GCTs and 19 human normal ovaries containing 68 follicles were stained immunohistochemically using monoclonal anti-beta-catenin and anti-E-cadherin antibodies. None of the 32 GCTs and none of the 68 ovarian follicles showed beta-catenin nuclear expression (0{\%}). On the other hand, 28 of 32 GCTs (88{\%}) and 53 of 68 normal ovarian follicles (78{\%}) showed nuclear expression of E-cadherin in granulosa cells. The ovarian stroma in all 19 normal ovaries showed nuclear expression of E-cadherin but not beta-catenin. Membranous and cytoplasmic expression was observed variously in ovarian GCT, follicles and stroma. Conclusions: We have confirmed frequent nuclear localization of E-cadherin but not beta-catenin in human ovarian GCT, ovarian follicles and stroma. There is no evidence of misregulated Wnt/beta-catenin signalling (represented by nuclear expression of beta-catenin) in human ovarian GCT. Nuclear translocation of E-cadherin might contribute to ovarian folliculogenesis or granulosa/stromal cell differentiation.",
author = "Yoshihiro Ohishi and Yoshinao Oda and Shuichi Kurihara and Tsunehisa Kaku and Hiroaki Kobayashi and Norio Wake and Masazumi Tsuneyoshi",
year = "2011",
month = "2",
day = "1",
doi = "10.1111/j.1365-2559.2011.03761.x",
language = "English",
volume = "58",
pages = "423--432",
journal = "Histopathology",
issn = "0309-0167",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Nuclear localization of E-cadherin but not beta-catenin in human ovarian granulosa cell tumours and normal ovarian follicles and ovarian stroma

AU - Ohishi, Yoshihiro

AU - Oda, Yoshinao

AU - Kurihara, Shuichi

AU - Kaku, Tsunehisa

AU - Kobayashi, Hiroaki

AU - Wake, Norio

AU - Tsuneyoshi, Masazumi

PY - 2011/2/1

Y1 - 2011/2/1

N2 - Aims: The role of misregulated Wnt/beta-catenin signalling in human ovarian granulosa cell tumour (GCT) has not been well characterized. The aim of this study was to confirm subcellular localization of key molecules of Wnt signalling (beta-catenin and E-cadherin) in human ovarian GCTs. Methods and results: Tissue samples taken from 32 human ovarian GCTs and 19 human normal ovaries containing 68 follicles were stained immunohistochemically using monoclonal anti-beta-catenin and anti-E-cadherin antibodies. None of the 32 GCTs and none of the 68 ovarian follicles showed beta-catenin nuclear expression (0%). On the other hand, 28 of 32 GCTs (88%) and 53 of 68 normal ovarian follicles (78%) showed nuclear expression of E-cadherin in granulosa cells. The ovarian stroma in all 19 normal ovaries showed nuclear expression of E-cadherin but not beta-catenin. Membranous and cytoplasmic expression was observed variously in ovarian GCT, follicles and stroma. Conclusions: We have confirmed frequent nuclear localization of E-cadherin but not beta-catenin in human ovarian GCT, ovarian follicles and stroma. There is no evidence of misregulated Wnt/beta-catenin signalling (represented by nuclear expression of beta-catenin) in human ovarian GCT. Nuclear translocation of E-cadherin might contribute to ovarian folliculogenesis or granulosa/stromal cell differentiation.

AB - Aims: The role of misregulated Wnt/beta-catenin signalling in human ovarian granulosa cell tumour (GCT) has not been well characterized. The aim of this study was to confirm subcellular localization of key molecules of Wnt signalling (beta-catenin and E-cadherin) in human ovarian GCTs. Methods and results: Tissue samples taken from 32 human ovarian GCTs and 19 human normal ovaries containing 68 follicles were stained immunohistochemically using monoclonal anti-beta-catenin and anti-E-cadherin antibodies. None of the 32 GCTs and none of the 68 ovarian follicles showed beta-catenin nuclear expression (0%). On the other hand, 28 of 32 GCTs (88%) and 53 of 68 normal ovarian follicles (78%) showed nuclear expression of E-cadherin in granulosa cells. The ovarian stroma in all 19 normal ovaries showed nuclear expression of E-cadherin but not beta-catenin. Membranous and cytoplasmic expression was observed variously in ovarian GCT, follicles and stroma. Conclusions: We have confirmed frequent nuclear localization of E-cadherin but not beta-catenin in human ovarian GCT, ovarian follicles and stroma. There is no evidence of misregulated Wnt/beta-catenin signalling (represented by nuclear expression of beta-catenin) in human ovarian GCT. Nuclear translocation of E-cadherin might contribute to ovarian folliculogenesis or granulosa/stromal cell differentiation.

UR - http://www.scopus.com/inward/record.url?scp=79952075269&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952075269&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2559.2011.03761.x

DO - 10.1111/j.1365-2559.2011.03761.x

M3 - Article

C2 - 21299609

AN - SCOPUS:79952075269

VL - 58

SP - 423

EP - 432

JO - Histopathology

JF - Histopathology

SN - 0309-0167

IS - 3

ER -